Business Weekly - Cambridge, UK

The strongest showing was a 33 per cent rise in Phytopharm in advance of the interim results out on May 1 – results that failed to meet the best of expectations, causing the share price to retreat by almost 10 per cent.

Arc International rose 20 per cent after a series of meetings with analysts and investors following the announcement earlier in April of the deal with Broadcom.

Plasmon continued its recovery with a further 18 per cent rise and MMI rose 14 per cent after the announcement that a 25-patient cancer study had met its objectives.

Of more impact on the Index were the 12 per cent rise in the shares of Mothercare after its acquisition of the Early Learning Centre and the rise of 9 per cent in Autonomy on its results and an intention to demerge its consumer unit, BlinkX.

Choices UK fell a further 44 per cent after the 55 per cent fall the previous week.

Centurion Electronics, the in-car entertainment systems group, fell 21 per cent, but with no published news. apart from these two no stock fell by as much as 9 per cent.